Clinical Trial Update: Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating posaconazole prophylaxis during ATG treatment in patients with aplastic anemia or myelodysplastic syndromes; the study is completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Myelodysplastic Syndromes

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Aplastic Anemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2024-12-20